ECHS1 and cancer: As metabolic organs are directly exposed to high levels of glucose and other nutrients, we predicted that hyperacetylated and inactivated ECHS1 accumulated BCAAs and FAs; therefore, increased BCL-2 expression would be observed in cancers originating from these organs.